John A. Merhige is Chief Commercial Officer at Credence MedSystems. Previously, he was Vice-President, Market Development at Sanofi BioSurgery. He came to Sanofi upon its acquisition of Pluromed in 2012, which John joined in its early stages and where he was a member of the executive management team. He led the commercial activities at Pluromed, which developed and commercialised rapid transition polymers for cardiovascular and other surgical procedures. Prior to Pluromed, John founded Prelude Devices to target early-stage medical device technologies for development and commercialisation. John is a member of PDA, MassMEDIC, MassBio and has served on the board of directors of the MedDev Group
Bjarne Sørensen and John A. Merhige explore the latest developments in modular autoinjector platforms and the benefits for end users and pharmaceutical customers. They also discuss the two companies’ recent partnership for the development of a combined system that capitalises on important synergies between two compatible technologies.
Featuring for the first time in ONdrugDelivery Magazine, John A. Merhige introduces the Credence Companion Safety Syringes System. This innovative, modular technology provides fully customisable needle safety without coming into contact with the drug prior to use and without any change to the existing primary drug container.